Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
What This Means for Patients in Shreveport and the Ark-La-Tex Louisiana consistently ranks among the top three states in the country for obesity prevalence
Oxid Med Cell Longev, 2019
As of November 2025, Lillys Mounjaro held 86% of the market share in doses, while Wegovy held the rest
(First patent filing for exendin-4) Novo Nordisk
These risks necessitate a careful assessment of patient history and ongoing monitoring during treatment
US$ 23.99
US$ 28.27
US$ 29.06
US$ 23.04
US$ 28.91
